|
2025
|
Invention
|
Benzotriazole compound.
The present invention aims to provide a medicament capable of treating a... |
|
2024
|
Invention
|
Benzotriazole compound. The present invention aims to provide a medicament capable of treating an... |
|
2023
|
Invention
|
Benzothiophene compound.
The present invention aims to provide a medicament capable of treating ... |
|
|
Invention
|
Benzothiophene compound. The present invention addresses the problem of providing a medicinal dru... |
|
|
Invention
|
Benzotriazole compound. The present invention addresses the problem of providing a medicine capab... |
|
2019
|
Invention
|
Novel polymer-active drug conjugate and use thereof. The present invention addresses the problem ... |
|
|
Invention
|
Cdk8 inhibitor and use of same. The present invention provides a novel CDK8 inhibitor. The presen... |
|
|
Invention
|
Ptp-1b inhibitor and use thereof. The present invention pertains to a compound represented by gen... |
|
|
Invention
|
Readthrough inducer and pharmaceutical use thereof. The present invention pertains to a compound ... |
|
2018
|
Invention
|
Protein-binding drug. Provided is a compound that, after administration into an organism, rapidly... |
|
|
Invention
|
Cyclin-dependent kinase 8 and/or 19 inhibitor. The present invention aims to provide a novel cycl... |
|
|
Invention
|
Read-through inducing agent and pharmaceutical application thereof. The present invention relates... |
|
|
Invention
|
Novel cyclin-dependent kinase 8 and/or 19 inhibitor. The present invention addresses the problem ... |
|
2015
|
Invention
|
Novel anticancer agent. The purpose of the present invention is to provide a useful prodrug comp... |
|
2014
|
Invention
|
Aromatic compound and use thereof. Provided is a compound showing a bone formation promoting acti... |
|
|
Invention
|
Novel aromatic compound and use thereof. Provided is a compound which exhibits bone formation acc... |
|
|
Invention
|
Therapeutic agent for diabetes. Provided is a compound having PTP-1B inhibitory activity that is ... |
|
2011
|
Invention
|
Heterocyclic compound. The present invention is based on the founding of a novel heterocyclic com... |
|
2009
|
Invention
|
Orally disintegrating tablets. Disclosed is an orally disintegrating tablet comprising (1) an act... |
|
2006
|
Invention
|
Composition for oral administration. Disclosed are: a composition for oral administration which e... |
|
|
Invention
|
Tetrahydroisoquinoline compound and medicinal use thereof.
The present invention provide a tetra... |
|
|
Invention
|
Tetrahydroisoquinoline compound and medicinal use thereof. A tetrahydroisoquinoline compound, in ... |
|
2004
|
Invention
|
Insulin resistance curative and method of screening the same. The present invention provides a sc... |
|
|
Invention
|
Insulin resistance curative and method of screening the same. A method of screening a highly safe... |
|
2003
|
Invention
|
Heterocyclic compound and medicinal use thereof. The novel heterocyclic compound of the present i... |
|
|
Invention
|
Heterocyclic derivatives and medicinal use thereof. 20 is optionally substituted phenyl, and n is... |
|
|
Invention
|
Carbapenem compound. A carbapenem compound represented by the formula (I′):
1
wherein ea... |
|
|
Invention
|
Indoline compound and medicinal use thereof. The present invention provides an indoline compound ... |
|
|
Invention
|
Novel indoline compound and medicinal use thereof. An indoline compound represented by the genera... |
|
2002
|
Invention
|
Heterocyclic compounds and salts thereof and medicinal use of the same. A heterocyclic compound o... |
|
|
Invention
|
Novel heterocyclic compound and medicinal use thereof. A novel heterocyclic compound which is eit... |
|
|
Invention
|
Novel heterocyclic derivatives and medicinal use thereof. Novel heterocyclic derivatives represen... |
|
|
Invention
|
Carbapenem compound. A carbapenem compound represented by the formula ࿈I')ᛢ ࿈I'&rp... |
|
|
Invention
|
Method of preserving foaming suppository. A method of preserving a foaming suppository characteri... |
|
2001
|
Invention
|
Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation ... |
|
2000
|
Invention
|
Novel heterocyclic compounds and salts thereof and medicinal use of the same. Heterocyclic compou... |
|
|
Invention
|
Carbapenem compounds, use of the same and intermediates thereof. Carbapenem compounds represented... |
|
|
Invention
|
Carbapenem derivatives, utilization thereof and intermediate compounds of the same. A carbapenem ... |
|
|
Invention
|
Medicinal use of cromoglycic acid compounds. has an antirheumatic action, an antiinflammatory act... |
|
|
Invention
|
Inhibitors for optic hypofunction caused by optic nerve cell injury induced by factors other than... |
|
|
Invention
|
Heterocyclic derivatives and pharmaceutical use thereof. wherein each symbol is as defined in the... |
|
1999
|
Invention
|
Carbapenem compounds, use thereof, and intermediate compounds of the same. A carbapenem compound ... |
|
|
Invention
|
Carbapenem derivatives, utilization thereof and intermediate compounds of the same. Carbapenem co... |
|
|
Invention
|
Drugs for ameliorating ocular circulatory disorders. An agent for ameliorating ocular circulatory... |
|
|
Invention
|
Therapeutic agent for allergic dermatitis. or a nontoxic salt thereof as an active ingredient. Th... |
|
1998
|
Invention
|
Antirheumatic agent. An antirheumatic agent comprising diethyl L-lysylcromoglycate of the followi... |
|
|
Invention
|
Indolyl or indolinyl derivatives and medicinal use thereof as acat or lipid peroxidation inhibito... |
